A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy. The trial, conducted by the Diabetic Retinopathy Clinical Research Network (DRCR.net) compared Lucentis with a type of laser therapy called panretinal or scatter photocoagulation, which has remained the gold standard for proliferative diabetic retinopathy since the mid-1970s. The findings demonstrate the first major therapy advance in nearly 40 years.

Related posts:

  1. Medicare Card, Eylea outperforms other drugs for diabetic macular edema with moderate or worse vision loss Medicare Card, Eylea outperforms other drugs for diabetic macular edema with moderate or worse vision loss...
  2. Medicare Card, Sharp rise in diabetic eye disease makes American Diabetes Month ever more important Medicare Card, Sharp rise in diabetic eye disease makes American Diabetes Month ever more important...
  3. NIH-Supported ACCORD Eye Study Finds Two Therapies Slow Diabetic Eye Disease Progression In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans....
  4. Medicare, Aiming for Near-Normal, Blood Sugar Did Not Delay Combined Risk of Diabetic Damage for People With Long-standing Diabetes, NIH-Sponsored Trial Finds In people with longstanding type 2 diabetes who are at high risk for heart attack and stroke, lowering blood sugar to near-normal levels did not delay the combined risk of diabetic damage to kidneys, eyes, or nerves, but did delay several other signs of diabetic damage, a study has found. The intensive glucose treatment was […]...
  5. Strategy Confirmed to Help Doctors, Determine When to Treat Retinopathy of Prematurity Scientists have shown that through an eye exam, doctors can identify infants who are most likely to benefit from early treatment for a potentially blinding eye condition called retinopathy of prematurity (ROP), resulting in better vision for many children....
  6. Avastin and Lucentis are equivalent in treating age-related macular degeneration At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although greater improvements in vision were seen with monthly administration for this common, debilitating eye disease, according to researchers supported by the National Institutes of […]...
  7. Medicare Card, NIH clinical trial begins for treatment of rare, fatal neurological disorder Medicare Card, NIH clinical trial begins for treatment of rare, fatal neurological disorder...
  8. Medicare Card, Adding chemotherapy following radiation treatment improves survival for adults with a slow-growing type of brain tumor Medicare Card, Adding chemotherapy following radiation treatment improves survival for adults with a slow-growing type of brain tumor...
  9. Medicare Card, NIH-funded study points way forward for retinal disease gene therapy Medicare Card, NIH-funded study points way forward for retinal disease gene therapy...
  10. Funded study shows reduction in death for men with intermediate-grade prostate cancer Short-term hormone therapy given in combination with radiation therapy to men with early-stage prostate cancer increased their chances of living longer compared to treatment with radiation therapy alone, according to a clinical trial supported by the National Cancer Institute (NCI), part of the National Institutes of Health. Benefits of the combined treatment were limited mainly […]...
  11. Genetic abnormality predicts benefit from treatment for a rare brain tumor A clinical trial has shown that addition of chemotherapy to radiation therapy leads to a near doubling of median survival time in patients with a form of brain tumor (oligodendroglioma) that carries a chromosomal abnormality called the 1p19q co-deletion....
  12. Paralyzed individuals use thought-controlled robotic arm to reach and grasp In an ongoing clinical trial, a paralyzed woman was able to reach for and sip from a drink on her own — for the first time in nearly 15 years — by using her thoughts to direct a robotic arm. The trial, funded in part by the National Institutes of Health, is evaluating the safety […]...
  13. MedicareCard.com Comparative-Effectiveness Study Confirms New Treatment for Diabetic Macular Edema Researchers have shown that ranibizumab (Lucentis) eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of the retina....
  14. Medicare Card, NIH launches largest clinical trial focused on HIV-related cardiovascular disease Medicare Card, NIH launches largest clinical trial focused on HIV-related cardiovascular disease...
  15. Medicare Card, Help Cure a Disease You Care About Medicare Card, Help Cure a Disease You Care About...